Loading...

Mitochondrial Disease News


Gene therapy injection in one eye surprises scientists by improving vision in both

LHON RELATED: Injecting a gene therapy vector into one eye of someone suffering from LHON, the most common cause of mitochondrial blindness, significantly improves vision in both eyes, scientists...


Why does exercise make some people healthier than others? Pennington scientists will try to find out

STUDY SEEKS ANSWERS THROUGH CLOSER LOOK AT MITOCHONDRIA: Owen Carmichael Why do some people benefit so much from exercise while others enjoy few health gains or even suffer harm?...


The European Commission Approves Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Dravet Syndrome

RE: EPILEPSY – DRAVEY SYNDROME: EMERYVILLE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing rare disease therapies, announced today that the European...


Reducing proton leak restores function in aging heart cells

ELAMPRETIDE RELATED: A drug to improve heart function, elamipretide, stanches proton leaks in aged heart cell mitochondria. Scientists have revealed a mechanism that causes heart cells to age and...


Researchers discover novel mechanism by which cells turn over mitochondria

PARKINSON’S RELATED, A LOOK AT MITOCHONDRIAL TUNROVER: Mitochondria are cellular organelles that generate most of the energy cells need to function, and thus play an important role in maintaining...


Isha Jain Joins Gladstone Institutes

RESEARCHER IN MITOCHONRIA: SAN FRANCISCO, Dec. 16, 2020 /PRNewswire/ — Oxygen is vital for all life, but in the human body, the level of oxygen must be just right....


How a very ‘sociable’ protein can hold clues about Alzheimer’s origin

AGING RELATED: Using the ESRF cryo-electron microscope and Small Angle X-ray Scattering at the ESRF’s beamline BM29, the researchers managed to decipher the role of ECSIT in mitochondrial activity....


Nuclear receptors protect against kidney disease

In terms of cellular diversity, it may not be the brain, but the kidney boasts more cell types than most other organs. Now, researchers at the Institute for Bioengineering...


Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome

Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I Efficacy endpoints demonstrated statistically significant and clinically meaningful reductions in Rett syndrome...


Friedreich’s Ataxia Center of Excellence at CHOP Awarded $1.275 Million to Advance Medical Research

(COE) at Children’s Hospital of Philadelphia (CHOP) was awarded $1.275 million by the Friedreich’s Ataxia Research Alliance (FARA), along with the Hamilton and Finneran families and the CureFA Foundation,...